Cargando…

AMP-activated protein kinase – not just an energy sensor

Orthologues of AMP-activated protein kinase (AMPK) occur in essentially all eukaryotes as heterotrimeric complexes comprising catalytic α subunits and regulatory β and γ subunits. The canonical role of AMPK is as an energy sensor, monitoring levels of the nucleotides AMP, ADP, and ATP that bind comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Hardie, David Grahame, Lin, Sheng-Cai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615778/
https://www.ncbi.nlm.nih.gov/pubmed/29034085
http://dx.doi.org/10.12688/f1000research.11960.1
_version_ 1783266664838594560
author Hardie, David Grahame
Lin, Sheng-Cai
author_facet Hardie, David Grahame
Lin, Sheng-Cai
author_sort Hardie, David Grahame
collection PubMed
description Orthologues of AMP-activated protein kinase (AMPK) occur in essentially all eukaryotes as heterotrimeric complexes comprising catalytic α subunits and regulatory β and γ subunits. The canonical role of AMPK is as an energy sensor, monitoring levels of the nucleotides AMP, ADP, and ATP that bind competitively to the γ subunit. Once activated, AMPK acts to restore energy homeostasis by switching on alternate ATP-generating catabolic pathways while switching off ATP-consuming anabolic pathways. However, its ancestral role in unicellular eukaryotes may have been in sensing of glucose rather than energy. In this article, we discuss a few interesting recent developments in the AMPK field. Firstly, we review recent findings on the canonical pathway by which AMPK is regulated by adenine nucleotides. Secondly, AMPK is now known to be activated in mammalian cells by glucose starvation by a mechanism that occurs in the absence of changes in adenine nucleotides, involving the formation of complexes with Axin and LKB1 on the surface of the lysosome. Thirdly, in addition to containing the nucleotide-binding sites on the γ subunits, AMPK heterotrimers contain a site for binding of allosteric activators termed the allosteric drug and metabolite (ADaM) site. A large number of synthetic activators, some of which show promise as hypoglycaemic agents in pre-clinical studies, have now been shown to bind there. Fourthly, some kinase inhibitors paradoxically activate AMPK, including one (SU6656) that binds in the catalytic site. Finally, although downstream targets originally identified for AMPK were mainly concerned with metabolism, recently identified targets have roles in such diverse areas as mitochondrial fission, integrity of epithelial cell layers, and angiogenesis.
format Online
Article
Text
id pubmed-5615778
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-56157782017-10-12 AMP-activated protein kinase – not just an energy sensor Hardie, David Grahame Lin, Sheng-Cai F1000Res Review Orthologues of AMP-activated protein kinase (AMPK) occur in essentially all eukaryotes as heterotrimeric complexes comprising catalytic α subunits and regulatory β and γ subunits. The canonical role of AMPK is as an energy sensor, monitoring levels of the nucleotides AMP, ADP, and ATP that bind competitively to the γ subunit. Once activated, AMPK acts to restore energy homeostasis by switching on alternate ATP-generating catabolic pathways while switching off ATP-consuming anabolic pathways. However, its ancestral role in unicellular eukaryotes may have been in sensing of glucose rather than energy. In this article, we discuss a few interesting recent developments in the AMPK field. Firstly, we review recent findings on the canonical pathway by which AMPK is regulated by adenine nucleotides. Secondly, AMPK is now known to be activated in mammalian cells by glucose starvation by a mechanism that occurs in the absence of changes in adenine nucleotides, involving the formation of complexes with Axin and LKB1 on the surface of the lysosome. Thirdly, in addition to containing the nucleotide-binding sites on the γ subunits, AMPK heterotrimers contain a site for binding of allosteric activators termed the allosteric drug and metabolite (ADaM) site. A large number of synthetic activators, some of which show promise as hypoglycaemic agents in pre-clinical studies, have now been shown to bind there. Fourthly, some kinase inhibitors paradoxically activate AMPK, including one (SU6656) that binds in the catalytic site. Finally, although downstream targets originally identified for AMPK were mainly concerned with metabolism, recently identified targets have roles in such diverse areas as mitochondrial fission, integrity of epithelial cell layers, and angiogenesis. F1000Research 2017-09-22 /pmc/articles/PMC5615778/ /pubmed/29034085 http://dx.doi.org/10.12688/f1000research.11960.1 Text en Copyright: © 2017 Hardie DG and Lin SC http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Hardie, David Grahame
Lin, Sheng-Cai
AMP-activated protein kinase – not just an energy sensor
title AMP-activated protein kinase – not just an energy sensor
title_full AMP-activated protein kinase – not just an energy sensor
title_fullStr AMP-activated protein kinase – not just an energy sensor
title_full_unstemmed AMP-activated protein kinase – not just an energy sensor
title_short AMP-activated protein kinase – not just an energy sensor
title_sort amp-activated protein kinase – not just an energy sensor
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615778/
https://www.ncbi.nlm.nih.gov/pubmed/29034085
http://dx.doi.org/10.12688/f1000research.11960.1
work_keys_str_mv AT hardiedavidgrahame ampactivatedproteinkinasenotjustanenergysensor
AT linshengcai ampactivatedproteinkinasenotjustanenergysensor